| 1 |
30305355 | Defining HIV-1 Envelope N-Glycan Microdomains through Site-Specific Heterogeneity Profiles. | 2019 Jan 1 |
3 |
| 2 |
31028779 | Protein and Glycan Mimicry in HIV Vaccine Design. | 2019 May 31 |
1 |
| 3 |
29343613 | Restricted HIV-1 Env glycan engagement by lectin-reengineered DAVEI protein chimera is sufficient for lytic inactivation of the virus. | 2018 Mar 9 |
3 |
| 4 |
29579062 | Heterogeneity in glycan composition on the surface of HIV-1 envelope determines virus sensitivity to lectins. | 2018 |
7 |
| 5 |
29718999 | Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation. | 2018 May |
2 |
| 6 |
30115684 | Metabolic labeling of HIV-1 envelope glycoprotein gp120 to elucidate the effect of gp120 glycosylation on antigen uptake. | 2018 Sep 28 |
1 |
| 7 |
30302011 | Structural Rearrangements Maintain the Glycan Shield of an HIV-1 Envelope Trimer After the Loss of a Glycan. | 2018 Oct 9 |
1 |
| 8 |
30355496 | Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth. | 2018 Oct 23 |
3 |
| 9 |
27984693 | Global N-Glycan Site Occupancy of HIV-1 gp120 by Metabolic Engineering and High-Resolution Intact Mass Spectrometry. | 2017 Feb 17 |
1 |
| 10 |
28202756 | Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers. | 2017 May 1 |
1 |
| 11 |
28322582 | Short Communication: Manα1-2Man-Binding Anti-HIV Lectins Enhance the Exposure of V2i and V3 Crown Neutralization Epitopes on the V1/V2 and V3 Hypervariable Loops of HIV-1 Envelope. | 2017 Sep |
1 |
| 12 |
28445724 | Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation. | 2017 Apr 25 |
1 |
| 13 |
28446609 | Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity. | 2017 Jun 16 |
1 |
| 14 |
28514685 | Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop. | 2017 May 16 |
1 |
| 15 |
28632942 | The glycan-mediated mechanism on the interactions of gp120 with CD4 and antibody: Insights from molecular dynamics simulation. | 2017 Dec |
1 |
| 16 |
28729420 | Revisiting the substrate specificity of mammalian α1,6-fucosyltransferase reveals that it catalyzes core fucosylation of N-glycans lacking α1,3-arm GlcNAc. | 2017 Sep 8 |
1 |
| 17 |
28947103 | Interrogation of side chain biases for oligomannose recognition by antibody 2G12 via structure-guided phage display libraries. | 2017 Oct 15 |
1 |
| 18 |
28994411 | X-ray and EM structures of a natively glycosylated HIV-1 envelope trimer. | 2017 Oct 1 |
5 |
| 19 |
29107699 | Synthetic Three-Component HIV-1 V3 Glycopeptide Immunogens Induce Glycan-Dependent Antibody Responses. | 2017 Dec 21 |
1 |
| 20 |
26512079 | Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites. | 2016 Jan 15 |
4 |
| 21 |
26537503 | Roles of glycans in interactions between gp120 and HIV broadly neutralizing antibodies. | 2016 Mar |
4 |
| 22 |
26972002 | Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein. | 2016 Mar 22 |
1 |
| 23 |
27067056 | Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor. | 2016 Apr 19 |
1 |
| 24 |
27114034 | Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G. | 2016 May 5 |
7 |
| 25 |
27258397 | Probability of N332 glycan occupancy on HIV-1 gp120 modulates sensitivity to broadly neutralizing antibodies. | 2016 Sep 10 |
5 |
| 26 |
27449907 | Fragments of the V1/V2 domain of HIV-1 glycoprotein 120 engineered for improved binding to the broadly neutralizing PG9 antibody. | 2016 Sep |
1 |
| 27 |
27489265 | Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan. | 2016 Oct 15 |
1 |
| 28 |
27576440 | HIV-1 clade C escapes broadly neutralizing autologous antibodies with N332 glycan specificity by distinct mechanisms. | 2016 Aug 30 |
1 |
| 29 |
27617431 | Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site. | 2016 Oct |
1 |
| 30 |
25546301 | Crystal structure of a fully glycosylated HIV-1 gp120 core reveals a stabilizing role for the glycan at Asn262. | 2015 Mar |
1 |
| 31 |
25878100 | Glycan Microheterogeneity at the PGT135 Antibody Recognition Site on HIV-1 gp120 Reveals a Molecular Mechanism for Neutralization Resistance. | 2015 Jul |
1 |
| 32 |
26085151 | Cell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 Envelope. | 2015 Sep |
3 |
| 33 |
26277072 | Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans. | 2015 Sep 22 |
1 |
| 34 |
26355155 | Reactivation of Neutralized HIV-1 by Dendritic Cells Is Dependent on the Epitope Bound by the Antibody. | 2015 Oct 15 |
2 |
| 35 |
26388028 | Model Building and Refinement of a Natively Glycosylated HIV-1 Env Protein by High-Resolution Cryoelectron Microscopy. | 2015 Oct 6 |
1 |
| 36 |
26798488 | Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune Response. | 2015 Oct-Dec |
1 |
| 37 |
24872420 | HIV-1 envelope proteins and V1/V2 domain scaffolds with mannose-5 to improve the magnitude and quality of protective antibody responses to HIV-1. | 2014 Jul 25 |
1 |
| 38 |
24992528 | Transplanting supersites of HIV-1 vulnerability. | 2014 |
2 |
| 39 |
25016576 | Characterization of a monoclonal antibody to a novel glycan-dependent epitope in the V1/V2 domain of the HIV-1 envelope protein, gp120. | 2014 Nov |
2 |
| 40 |
25275130 | HIV-1 envelope glycan moieties modulate HIV-1 transmission. | 2014 Dec |
4 |
| 41 |
25403811 | The characteristic structure of anti-HIV actinohivin in complex with three HMTG D1 chains of HIV-gp120. | 2014 Dec 15 |
1 |
| 42 |
23221565 | 2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies. | 2013 Feb |
1 |
| 43 |
23384254 | A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization. | 2013 Feb 6 |
1 |
| 44 |
23708606 | Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. | 2013 Jul |
1 |
| 45 |
23767872 | Conference report: "Functional Glycomics in HIV Type 1 Vaccine Design" workshop report, Bethesda, Maryland, April 30-May 1, 2012. | 2013 Nov |
1 |
| 46 |
23831758 | Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies. | 2013 Aug |
1 |
| 47 |
23895096 | Role of cations in the interaction of pradimicins with HIV-1 envelope gp120. | 2013 Aug |
1 |
| 48 |
24051158 | Elicitation of broadly reactive antibodies against glycan-modulated neutralizing V3 epitopes of HIV-1 by immune complex vaccines. | 2013 Nov 4 |
1 |
| 49 |
24097413 | Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activity. | 2013 Nov |
1 |
| 50 |
22192629 | Highly conserved HIV-1 gp120 glycans proximal to CD4-binding region affect viral infectivity and neutralizing antibody induction. | 2012 Feb 5 |
1 |